Today, DSW (Deutsche Stiftung Weltbevoelkerung) launched a brand new publication, titled Innovations in Global Health Research and Develop

Today marks the first day of vaccinations for Phase I, Part II clinical testing of Sabin's human hookworm vaccine in Brazil.

This month, the Sabin Vaccine Institute will begin a Phase-1 clinical trial in Washington, DC to further investigate the Na-GST-1 human hookworm vaccine candidate.